Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yangjiong Xiao"'
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The Exocrine Differentiation and Proliferation Factor (EXDPF) gene could promote exocrine while inhibit endocrine functions. Although it is well known that ovary is an endocrine organ, the functions of EXDPF in ovarian cancer development is still unk
Externí odkaz:
https://doaj.org/article/9b5d3e7ed9d4468484fb64dc34d79fdc
Autor:
Yangjiong Xiao, Yang Yu, Dan Gao, Wangrui Jin, Pengcheng Jiang, Yuhong Li, Chao Wang, Yuning Song, Peng Zhan, Fei Gu, Cancan Zhang, Bin Wang, Yihua Chen, Bing Du, Rong Zhang
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Novel inhibitors are urgently needed for use as targeted therapies to improve the overall survival (OS) of patients with ovarian cancer. Here, we show that cell division cycle 25B (CDC25B) is over-expressed in ovarian tumors and associated with poor
Externí odkaz:
https://doaj.org/article/556d2cc1dd674429a56e622ef0cf7ecf
Publikováno v:
Cellular Oncology. 43:669-680
The PI3K/AKT/mTOR pathway is one of the most highly activated cellular signaling pathways in advanced ovarian cancer. Although several PI3K/AKT/mTOR inhibitors have been developed to treat various types of cancer, the antitumor efficacy of many of th
Autor:
Yonghui Li, Yangjiong Xiao, Zuowei Li, Qiang Fu, Dongliang Yan, Tao Liang, Hongmei Song, Yan Jiang
Publikováno v:
Scientific Reports
Development of castration resistance is a key contributor to mortality in patients with prostate cancer. High expression of RING finger protein 7 (RNF7) in cancer cells is known to play a key role in tumor progression. However, the role of RNF7 in pr